Results 331 to 340 of about 1,679,247 (398)
Factors related to acute heart failure in systemic sclerosis. [PDF]
Sener YZ, Sener S.
europepmc +1 more source
Mapping protein–protein interactions by mass spectrometry
Abstract Protein–protein interactions (PPIs) are essential for numerous biological activities, including signal transduction, transcription control, and metabolism. They play a pivotal role in the organization and function of the proteome, and their perturbation is associated with various diseases, such as cancer, neurodegeneration, and infectious ...
Xiaonan Liu+4 more
wiley +1 more source
Pharmacological management of pain in digital ulcers of systemic sclerosis: A PRISMA-driven systematic review. [PDF]
Almeida I, Dourado A, Agualusa L.
europepmc +1 more source
This study demonstrated significant treatment efficacy and safety of incobotulinumtoxinA injection in Japanese patients with chronic sialorrhea caused by Parkinson's disease and other neurological conditions. Suppression of salivary secretion and improvement in drooling symptoms were also observed throughout 48 weeks.
Nobutaka Hattori+15 more
wiley +1 more source
Frequency and implications of malnutrition in systemic sclerosis. [PDF]
Fairley JL+11 more
europepmc +1 more source
Cell Apoptosis and Glucocorticoid‐Induced Osteonecrosis
The review identifies glucocorticoid‐induced osteocyte/osteoblast apoptosis as central to femoral head osteonecrosis (GION), mediated through STAT1‐caspase‐3, PI3K/Akt, Wnt/β‐catenin, and oxidative stress pathways. Emerging therapies targeting these pathways (e.g., HIF‐1α stabilization, AMPK activation, and exosome‐mediated miRNA delivery) show ...
Xiumei Tang+7 more
wiley +1 more source
Global Disease Burden of Immune‐Mediated Inflammatory Diseases (IMIDs), 1990–2021
This study provides the first standardized evaluation of the direct health burden of inflammatory and immune‐mediated diseases (IMIDs) across 231 locations worldwide from 1990 to 2021, spanning five geographic levels: global, SDI regions, GBD regions, countries, and territories.
Xueping Zhu+7 more
wiley +1 more source
Upadacitinib as a potential management option for diffuse cutaneous systemic sclerosis: A case report. [PDF]
Sarfaraz S, Chang J, Kirchhof MG.
europepmc +1 more source
Malignancy-associated risk factors in patients with systemic sclerosis. [PDF]
Baysal S+7 more
europepmc +1 more source